These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7229793)

  • 1. Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: correction by glucocorticoid therapy.
    Chesney RW; Hamstra AJ; DeLuca HF; Horowitz S; Gilbert EF; Hong R; Borcherding W
    J Pediatr; 1981 Jun; 98(6):919-22. PubMed ID: 7229793
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25 dihydroxyvitamin D.
    Frame B; Parfitt AM
    Ann Intern Med; 1980 Sep; 93(3):449-51. PubMed ID: 7436165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.
    Papapoulos SE; Clemens TL; Fraher LJ; Lewin IG; Sandler LM; O'Riordan JL
    Lancet; 1979 Mar; 1(8117):627-30. PubMed ID: 85869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
    Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
    J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.
    Barbour GL; Coburn JW; Slatopolsky E; Norman AW; Horst RL
    N Engl J Med; 1981 Aug; 305(8):440-3. PubMed ID: 6894783
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis.
    Koide Y; Kugai N; Kimura S; Fujita T; Yamashita N; Hiramoto ; Sukegawa J; Ogata E; Yamashita K
    J Clin Endocrinol Metab; 1981 Mar; 52(3):494-8. PubMed ID: 6257749
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
    Stern PH; De Olazabal J; Bell NH
    J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia.
    Kuchay MS; Mishra SK; Bansal B; Farooqui KJ; Sekhar L; Mithal A
    Arch Osteoporos; 2017 Dec; 12(1):68. PubMed ID: 28726113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
    Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
    J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids.
    Chesney RW; Mazess RB; Hamstra AJ; DeLuca HF; O'Reagan S
    Lancet; 1978 Nov; 2(8100):1123-5. PubMed ID: 82684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with cystic fibrosis.
    Weisman Y; Reiter E; Stern RC; Root A
    J Pediatr; 1979 Sep; 95(3):416-8. PubMed ID: 469668
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis.
    Kavathia D; Buckley JD; Rao D; Rybicki B; Burke R
    Respir Med; 2010 Apr; 104(4):564-70. PubMed ID: 20071158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D metabolites in idiopathic infantile hypercalcaemia.
    Martin ND; Snodgrass GJ; Cohen RD; Porteous CE; Coldwell RD; Trafford DJ; Makin HL
    Arch Dis Child; 1985 Dec; 60(12):1140-3. PubMed ID: 3879160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D concentrations in femoral neck fracture.
    Weisman Y; Salama R; Harell A; Edelstein S
    Br Med J; 1978 Oct; 2(6146):1196-7. PubMed ID: 719347
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D.
    Bell NH; Stern PH
    N Engl J Med; 1978 Jun; 298(22):1241-3. PubMed ID: 651964
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma 1,25-dihydroxyvitamin D concentrations in cords, newborns, infants, and children.
    Seino Y; Shimotsuji T; Yamaoka K; Ishida M; Ishii T; Matsuda S; Ikehara C; Yabuuchi H; Dokoh S
    Calcif Tissue Int; 1980; 30(1):1-3. PubMed ID: 6767527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation.
    Kumar R; Cohen WR; Silva P; Epstein FH
    J Clin Invest; 1979 Feb; 63(2):342-4. PubMed ID: 429557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D in paired maternal-cord sera.
    Weisman Y; Occhipinti M; Knox G; Reiter E; Root A
    Am J Obstet Gynecol; 1978 Mar; 130(6):704-7. PubMed ID: 637086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 1,25-dihydroxyvitamin D in bone disease.
    N Engl J Med; 1979 Feb; 300(8):434-5. PubMed ID: 759924
    [No Abstract]   [Full Text] [Related]  

  • 20. A specific competitive protein binding assay for serum 24,25-dihydroxyvitamin D in normal children and patients with nephrotic syndrome.
    Shimotsuji T; Hiejima T; Seino Y; Yamaoka K; Ishii T; Ishida M; Matsuda S; Ikehara C; Yabuuchi H
    Clin Chim Acta; 1980 Sep; 106(2):145-54. PubMed ID: 6967783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.